Molecule Details
| InChIKey | ODZBBRURCPAEIQ-PIXDULNESA-N |
|---|---|
| Compound Name | Brivudine |
| Canonical SMILES | O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1/C=C/Br |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.81 |
| Source | ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB03312 |
|---|---|
| Drug Name | Brivudine |
| CAS Number | 69304-47-8 |
| Groups | approved investigational |
| ATC Codes | J05AB15 |
| Description | Brivudine is used in the treatment of herpes zoster. Although not approved in the U.S. or Canada, it is approved in several European countries. |
Categories: Anti-Infective Agents Antiinfectives for Systemic Use Antiviral Agents Antivirals for Systemic Use Deoxyribonucleosides Deoxyuridine Direct Acting Antivirals Nucleic Acids, Nucleotides, and Nucleosides Nucleosides Nucleosides and Nucleotides Excl. Reverse Transcriptase Inhibitors Pyrimidine Nucleosides Pyrimidines
Cross-references: CHEMBL31634 ChemSpider: 394011 PDB: BVD PubChem:446727 PubChem:46505721 RxCUI: 59161 Wikipedia: Brivudine ZINC: ZINC000003653378